Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2025-12-30 00:00:00 ET · period of report 2025-12-30 · accession 0001104659-25-125233 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | 2025-12-30 | MBIO | Herskowitz Neil | Dir | S - Sale | $0.96 | -247 | 145 | -63% | -$237.12 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK, PAR VALUE $0.0001 | 2025-12-30 | S | D | 247 | $0.96 | 145 | D | — | — | (F1) Represents a private sale of 247 shares of common stock to another member of the board of directors of the Issuer. (F2) Effective January 15, 2025, the Issuer effected a one-for-fifty reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split. |